Combined treatment of pancreatic cancer xenograft with (90)Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor

AIM: To investigate the therapeutic effect of combined integrin α(6)β(4)-targeted radioimmunotherapy (RIT) and PI3K/mTOR inhibitor BEZ235 in a pancreatic cancer model. METHODS: Phosphorylation of Akt, mTOR, the downstream effectors eukaryotic initiation factor 4E binding protein 1 (4EBP1) and S6 rib...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung, Winn, Tsuji, Atsushi B, Sudo, Hitomi, Sugyo, Aya, Ukai, Yoshinori, Kouda, Katsushi, Kurosawa, Yoshikazu, Furukawa, Takako, Saga, Tsuneo, Higashi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698248/
https://www.ncbi.nlm.nih.gov/pubmed/29204055
http://dx.doi.org/10.3748/wjg.v23.i42.7551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698248/
https://www.ncbi.nlm.nih.gov/pubmed/29204055
http://dx.doi.org/10.3748/wjg.v23.i42.7551

Ejemplares similares